Background. Infections by multidrug-resistant organisms (MDROs) are a global threat and are particularly common in hospitals. This study was performed to assess the impact of hospital-acquired infections caused by MDROs on morbidity, mortality, and length of hospital stay.
Antimicrobial resistance is one of the most important global threats to public health. It undermines our ability to fight infectious diseases in the general population and reduces the chances of controlling infectious complications in the most vulnerable patients. In addition, when first-line antibiotic treatment fails or is limited by the presence of resistance, it is necessary to use more expensive antibiotics that are, sometimes, more toxic and less effective, increasing care costs and putting safety and effectiveness at risk [1] [2] [3] .
In the United States it has been estimated that >2 million people suffer infection by some multidrug-resistant organism (MDRO) each year and about 23 000 die as a direct result of these infections [2] . In the European Union, taking data from 2007, it has been estimated that MDRO infections cause about 25 000 deaths annually and generate an overall cost of about €1500 million per year [3] . In 2050, about 10 million people a year could die worldwide if the situation does not change [4] .
MDRO infections are particularly common in hospitals. Nearly 8% of hospitalized patients develop hospital-acquired infection (HAI), 20% of which could be caused by an MDRO [5, 6] . It is also estimated that more than a third of HAIs are preventable [5, 7] and that prevention could be one of the most important mechanisms to reduce the spread of MDROs [8] .
The measures commonly used to assess the impact of MDRO infections are mortality, length of stay (LOS), and cost. Sometimes other indicators of morbidity are used (stays in the intensive care unit [ICU] , reoperations, etc) [9, 10] . Most studies show that MDRO infections cause an increased risk in mortality (risk ratio [RR], 1.5-4.0) and an increase in stay of 2.0-12.7 days, and costs 1.2-1.5 times higher than those caused by susceptible strains [11] [12] [13] [14] [15] [16] [17] . However, studies that are based on these results are very heterogeneous, even contradictory, and they have limited comparability [18] [19] [20] . In addition, most studies have been limited to infections caused by a single organism in a single location, mainly bacteremia, in many cases, without differentiating whether the source of infection was hospital or community. In fact, very few studies [21, 22] have globally evaluated if nosocomial infections caused by main MDROs have a greater impact in terms of morbidity, mortality, and costs than susceptible microorganisms. The objective of our study was to analyze and evaluate the impact of HAIs produced by MDROs on morbidity and mortality and LOS in a university teaching hospital.
MATERIALS AND METHODS
A retrospective cohort study was designed targeting patients who developed an HAI from 2011 to 2014 at the Hospital Clínico Universitario of Zaragoza, Spain. Exposure (cases) was defined as any HAI caused by an MDRO (not present on or within 3 days of admission), be it surgical site infection (SSI), respiratory infection, urinary tract infection (UTI), or bloodstream infection (BSI). Exclusion criteria were age <18 years; admission to the services of obstetrics, pediatrics, or psychiatry; >1 infectious episode during admission; and infections by >1 MDRO. In the control group of patients, HAI had to be caused by the corresponding susceptible strains. Inclusion and exclusion criteria were the same.
The MDROs were grouped into 5 subtypes: (1) methicillin-resistant Staphylococcus aureus (MRSA); (2) linezolid-resistant Staphylococcus epidermidis; (3) vancomycin-resistant Enterococcus faecalis; (4) Escherichia coli and Klebsiella pneumoniae-producing extended-spectrum β-lactamase (ESBL) or AmpC cephamycinase plasmid; (5) Pseudomonas aeruginosa or Acinetobacter baumannii resistant to carbapenems (CR).
The outcome variables were in-hospital mortality from all causes (total and 30 days after HAI, both measured only while patients were in the hospital), LOS after infection in survivors (from the onset of infection to discharge), and 5 indirect indicators of morbidity: ICU admissions, need for surgery (any procedure performed in the operating room) or number of diagnostic tests after the HAI, and hospital readmissions or visits to the emergency department within 30 days of discharge.
The sources of information were the hospital records for the Surveillance and Control of Nosocomial Infections Program and patients' electronic history. The definition of the different types of HAI was made according to the criteria established by the Centers for Disease Control and Prevention [23] .
The main influence factors and confounders taken into account in the study are shown in Table 1 .
To calculate the sample size of each cohort, hospital mortality from all causes was considered as the primary endpoint (an estimated average of 25% was assigned). In addition, a confidence level of 95%, a statistical power of 80%, and a minimum ratio of 1.5 controls per each case was established. Once these parameters were set, the minimum number of individuals required to detect a risk ratio of at least 1.5 was 306 cases and 460 controls. However, for each case at least 2 controls were chosen whenever possible, matching by age (±10 years), sex, clinical specialty of admission, type of clinical unit (medical, surgical, or intensive care), year in which HAI was acquired, type of infection, and microorganism involved.
In descriptive analysis, the differences between qualitative variables were determined by χ 2 
Healthcare background
Hospital admission unit, history of previous hospitalizations, surgery, and stay in ICU were taken into account in the analysis.
Patient and HAI characteristics
Data were adjusted by main patient and HAI characteristics shown in Table 3 .
Causative pathogens
See the 5 subtypes of MDRO taken into account in "Methods"; infections by >1 MDRO were excluded.
Definitions of resistance
Any of the resistances included in each subtype of MDRO. We considered the resistance factor as a common or shared variable of exposure.
Location of infection side
We included all of the most common HAI: respiratory, urinary, bloodstream, or surgical site infections. Patients who had >1 infection episode were excluded. Data were adjusted by the type of infection involved.
Follow-up time
We followed all patients during the same period: from admission to discharge. Follow-up times (LOS post-HAI) were similar for both cases and control patient groups.
Antibiotic therapy
We did not have any measurement of appropriateness or delay in the antibiotic treatment. It is one of the study's limitations.
Outcome perspective
Only hospital perspective: patient morbidity (need for ICU, surgery, diagnostic test, 30-day readmissions, or visits to the emergency department), inpatient mortality (total and 30-day mortality, both measured only while patients were in the hospital), and LOS after infection.
Source: [18] [19] [20] .
Abbreviations: HAI, hospital-acquired infection; ICU, intensive care unit; LOS, length of stay; MDRO, multidrug-resistant organism.
hazards model, more appropriate to estimate the risk ratio from the hazard ratio (HR), when the frequency of the event in the study population is >10% [24] .
RESULTS

Descriptive Analysis
The final sample ( Figure 1 ) consisted of 1000 patients (324 cases and 676 controls). Most were male (55.9%) with a mean (± standard deviation) age of 71 ± 14.1 years and an average stay of 29.8 ± 20.6 days; 56.6% patients had undergone surgery, 24.2% were hospitalized, 15.9% were admitted to the ICU within 30 days prior to the HAI episode, and 51.6% were admitted to a surgical unit. HAI types studied were UTI (39.5%), SSI (33.8%), respiratory (18.4%), and BSI (8.3%). In the etiology of infection, E. coli was the most common organism (39.4%) followed by S. aureus (25.6%) and P. aeruginosa (18.2%).
The main characteristics of cases and controls are shown in Table 2 (matching variables) and Table 3 (other features). Both groups were similar in terms of the distribution of the main descriptive variables, except that controls had a higher frequency of neoplasms as primary diagnosis and HAI with polymicrobial etiology. Cases had a greater proportion of respiratory diseases, history of peripheral vascular disease, dementia and AIDS, a longer stay prior to HAI, increased frequency of previous hospitalizations, and higher severity of underlying disease according to McCabe index. All these differences were considered to adjust the results in multivariate models. 
Total and 30-Day In-hospital Mortality
The overall in-hospital mortality from all causes was significantly higher (P = .001) in cases (24.1%) than in controls (15.4%). Mortality was also associated with age, sex, Charlson comorbidity index, McCabe severity scale, onset of infection in the ICU, absence of surgical history, respiratory or bloodstream infections, and P. aeruginosa isolation in the etiology of HAI (Table 4) . After adjusting the data using Cox regression, (Table 5) .
Results in 30-day mortality (22.5% in cases and 14.5% in controls) were very similar to those of total mortality in the adjusted Cox model, both in the point estimate of the risk of exposure (HR, 1.77; 95% CI, 1.29-2.44) and in the other explanatory variables. We assumed that about 20% of HAIs are caused by MDROs and applied the formulas to calculate the etiological fraction risk in both exposed and in all infected patients. We therefore concluded that antibiotic resistance might cause >40% of deaths among patients with HAI-MDRO and up to 12% of the total HAI deaths.
Postinfection Length of Stay
The average postinfection LOS of patients who survived was slightly higher in cases (17.0 ± 17.3) than in controls (15.8 ± 15.6), although these differences did not have statistical significance (P = .339). In the multiple regression adjusted model, variables related to LOS were previous hospitalization, complicated diabetes history, ICU admission, polymicrobial etiology, and P. aeruginosa isolation in etiology.
30-Day Readmissions
Of patients discharged after an HAI-MDRO, 15.9% were readmitted within 30 days, compared to 8.0% of those infected with a sensitive strain (P = .001). In the logistic regression model, the exposure increased the probability of readmissions by 2.17 times (odds ratio [OR], 2.17; 95% CI, 1.36-3.46). Other variables associated with a higher probability of readmission were being admitted to different services instead of ICU, having had an HAI not related to UTI, and having a score of 2 on McCabe severity scale or a score of 3-4 on the Charlson comorbidity index (Table 6 ).
Visits to the Emergency Department Within 30 Days
Of patients with an HAI-MDRO, 28.5% attended the emergency department at least once within 30 days after discharge, compared to 16.1% of those in which a sensitive strain was involved (P = .000). Nevertheless, after adjustment by logistic regression, MDRO exposure as a whole ceased to be a factor associated with a higher probability of emergency department visits, except if they were HAIs produced by MRSA (OR, 2.80; 95% CI, 1.65-4.74) and E. coli resistant (OR, 2.28; 95% CI, 1.32-3.96). 
Need for Surgery, ICU Admission, or Diagnostic Tests
HAI-MDROs were not associated with an increased frequency of subsequent surgeries (15.4% vs 15.8%), ICU admissions (6.0% vs 9.8%; P = .08), or requests for diagnostic tests (13.6 ± 18.3 vs 11.6 ± 14.8; P = .08). Table 7 shows the main results for the type of microorganism involved in HAI in those outcome variables that were significant in the general analysis. MRSA showed an increased risk of both in-hospital mortality and 30-day readmissions or emergency department visits. Pseudomonas aeruginosa CR was only related with mortality and E. coli ESBL with 30-day readmissions and emergency department visits. HAI by K. pneumoniae ESBL did not appear to be associated with an increased risk in any of the outcomes analyzed.
Results for Each Type of Microorganism
DISCUSSION
The singularity of this study was to comprehensively assess the impact of the main spectrum of MDRO on patients with some of the most common HAIs. The results seem to confirm that MDROs increase the risk of hospital mortality in patients with an HAI (HR, 1.7), coinciding with 2 other studies in which the effect of various MDROs on several HAI types was studied [21, 22] and with many others in which the impact resistance of a single microorganism in a specific type of infection was investigated [13] [14] [15] [16] [17] . However, MRSA and P. aeruginosa CR appear to be the only ones responsible for this increase in mortality. Up to 40% of deaths in patients with an HAI-MDRO or 12% of all HAI deaths would be avoided if such resistance did not exist. It is still necessary to establish if antimicrobial resistance is a virulence factor itself [10, 25] , which would add more lethality to microorganisms, or if it is simply the cause of a greater therapeutic inadequacy and delay in the treatment of these infections, which would actually be the real cause of these worse outcomes [17, [26] [27] [28] [29] [30] .
Regardless of whether HAIs are caused by an MDRO or not, other factors associated with increased mortality were age, male sex, underlying conditions (McCabe and Charlson scales), ICU stay, and bacteremia. Age, sex, stay in ICU, and severity and comorbidity of patients (measured on various scales such as McCabe, Charlson, APACHE [Acute Physiology and Chronic Health Evaluation] or another) have been commonly found as factors independently associated with increased mortality in MDRO infections [18] , as well as several others such as cancer [31] , neutropenia [32] , liver disease [33] , immunosuppression [34] , use of invasive mechanical ventilation [35] , diabetes mellitus, and heart failure [35] , among others. In this aspect, our results are consistent with current knowledge.
In our study, bacteremia was shown to increase the risk of overall hospital mortality 2.49 times in patients with an HAI-MDRO. In previous studies, Micek ST et al [35] found that nosocomial pneumonias caused by carbapenem-resistant P. aeruginosa had higher mortality if accompanied by bacteremia. Lautenbach et al [36] , meanwhile, reported that the mortality of P. aeruginosa infections with resistance to imipenem was higher in patients with bacteremia, but not when the microorganism was isolated from other anatomical sites. Finally, in the study by Neidell et al [22] , bacteremia was associated with increased mortality in community infections, regardless of the organism and its resistance. Presence of microorganisms in blood reflects body defense mechanism failure with a greater risk of infection spread and severity [37] .
In our study, the postinfection LOS was not significantly higher in patients with an HAI-MDRO. Patients who died in the hospital were excluded from the LOS analysis to avoid the bias that could occur due to an increase in hospital mortality in any of the groups. Factors contributing to a longer stay were a complicated history of diabetes, previous hospitalization or ICU stay, acquisition of HAI in the ICU, and polymicrobial or P. aeruginosa etiology. There are also studies that show little or no effect of multidrug resistance on the extended LOS, both in ICU patients [38] and in the whole hospital [39] . In our opinion, severity and comorbidity are the main determinants of overstaying [10] . Both factors may be reflected in studies in different ways (history of specific diseases, risk scales, ICU stays, etc). Some infections increase the care needs of vulnerable patients; this may result in longer stay to tackle infection by a sensitive or resistant microorganism indistinctly [40] . Readmissions within 30 days after discharge are a quality indicator used internationally to assess hospital performance [41] . However, very few studies have addressed the relationship between readmissions and HAI [42, 43] , and even less in the specific case of HAI-MDROs. Our study is one of the first to address this issue in a direct way. The probability of readmission was more than 2 times higher (OR, 2.2) among those who had an HAI-MDRO, above all by MRSA or E. coli ESBL. MDRO could be responsible for a higher HAI recurrence rate [44] . This could lead to clinical decompensation of the underlying diseases due to infection, so patients would need new hospitalizations for better control of their clinical course.
HAI-MDRO also increased the probability of visiting the emergency department within 30 days after discharge, although these cases were limited to HAIs by MRSA (OR, 2.8) or E. coli resistance (OR, 2.3). We have not found this variable in similar studies; therefore, we cannot contrast it in any way. In the case of MRSA infections, the difficulty in eradicating the organism once it has colonized the human body has been reported [45] . As a consequence of that colonization, patients could suffer more frequent reinfections and subsequent emergency department visits. Escherichia coli-resistant infections showed an increased frequency of emergency department visits, likely related to the large number of comorbidities on infected patients and a higher susceptibility to clinical decompensations after discharge.
HAI-MDROs did not appear to increase the need for surgical intervention. This would be primarily related to the surgical nature of the infections themselves (history of previous surgery and SSI) and to the indicated therapeutic alternatives (drainage of abscesses, removal or replacement of infected prostheses, etc).
The relationship between MDROs and ICU infections is relatively well known; however, it is not clear if MDRO infections cause higher admission rates in ICU or if they are caused by the patient's underlying conditions [38] . According to our results, these other factors play a decisive role when patients with an HAI are moved to the ICU from other units. In these cases, severity of the patient's condition (measured in terms of previous stay in ICU and McCabe prognostic scale) and infections (respiratory infections and SSIs) could both act synergistically, causing clinical decompensations that require ICU admission regardless of whether the organism is sensitive or resistant.
Finally, according to our results, HAI-MDROs do not cause a greater number of diagnostic tests performed with respect to susceptible strains. This fact is more related to LOS, ICU stay, and patient severity. Only P. aeruginosa CR was shown as an independent factor in the number of laboratory tests performed, perhaps because P. aeruginosa CR is especially prevalent in these units and kinds of patients [14, 19] .
This study has several limitations. First, quality of records might be affected due to the retrospective design. Second, the attribution of mortality results to exposure could be questionable due to the lack of information on the real causes of death of patients. Third, we did not measure the appropriateness or delay in the antibiotic treatments, important factors that could influence the results. Fourth, we did not consider exposure as a time-dependent variable, which could bias the exposure effect [46] . Fifth, our study was done from a hospital perspective (other perspectives are needed). Finally, data from a single hospital provide internal validity but do not ensure external validity.
In conclusion, HAI-MDROs cause higher mortality, readmissions, and in some cases, emergency department visits after discharge. The results confirm the need to control the spread of MDRO infections that threaten global public health, current treatments of bacterial infections, and many medical advances. These infections do not seem to have any particular impact on the LOS, the need for surgery, diagnostic tests, or ICU admission. In such cases, the involved factors are related to the type of infection and to the severity of underlying patient condition.
Notes
